News

Johnson & Johnson Press Release  IRVINE, Calif. -- Johnson & Johnson today announced the commercial launch of the Dual Energy THERMOCOOL SMARTTOUCH SF (DE STSF) Platform in Europe, expanding physician access to a dual-energy...

AUSTIN, Texas—The Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center hosted its eighth international symposium on complex arrhythmias on May 28-29, 2026. This year’s event hosted a record 1,600 participants from around...

Murj Press Release SYDNEY and AUCKLAND, New Zealand, June 21, 2026 -- Murj®, a cardiac device management software company, today announced its official expansion into the Australian market alongside broader availability for New...

CHICAGO -- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced publication of successful multi-site validation of its software, which received U.S. Food and Drug...

HRS Press Release WASHINGTON, DC, June 8, 2026 – On Sunday, June 7, 2026, Danish soccer star Christian Eriksen, 34, collapsed on the playing field during a match against Ukraine in Copenhagen. Eriksen remained conscious and...

BIOTRONIK announces the first U.S. implant of its LivIQ leadless pacemaker as part of the BIO-LivIQ global pivotal clinical trial.

Smartphone-based heart rhythm monitoring from home can reduce same-day cancellations and help save significant healthcare resources ahead of planned electrical cardioversion in patients with atrial fibrillation.

Medtronic Press Release GALWAY, Ireland, June 3, 2026 -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced strategic investments in two privately held companies focused on the development...

Rhythm AI Press Release LA JOLLA, Calif., June 2, 2026 -- Rhythm AI, a MedTech company focused on optimizing atrial fibrillation (AF) procedures and developer of the STAR Apollo™ Mapping Software, today announced the appointment...

Cytokinetics Press Release SOUTH SAN FRANCISCO, Calif., and ZUG, Switzerland, June 01, 2026 -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the first commercial European launch of MYQORZO® (aficamten) in...